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Influence of obstructive sleep apnea on right heart structure 
and function
Abstract
Introduction: Obstructive sleep apnea syndrome (OSAS) is a highly prevalent sleep disorder associated with increased cardiovas-
cular morbidity and mortality. This study aimed to investigate heart structure and function and their correlation with the degree 
of OSAS and sleep indexes in patients diagnosed with OSAS.
Materials and methods: A cohort of 77patients (48 males, aged 58.1 ± 11.0 years, body mass index [BMI] = 32.4 ± 6.2) 
admitted to the hospital due to suspected OSAS was examined using echocardiography and polysomnography. 
Results: Patients with moderate-to-severe OSAS compared to patients without diagnosed OSAS or with mild OSAS had great-
er right ventricular outflow tract (RVOT) dimensions (32.6 ± 3.6 vs 30.9 ± 2.4 mm; p < 0.05), larger right atrial area (RAA; 
21.1 ± 4.8 vs 17.2 ± 3.2 mm; p = 0.002), greater right ventricular mid-cavity diameter (RVD; 35.5 ± 7.0 vs 32.2 ± 4.7 mm; 
p = 0.02), and diminished tricuspid annular plane systolic excursion (TAPSE, 21.9 ± 4.5 vs 25.8 ± 4.4 mm; p = 0.04), while 
there were no significant differences in tissue doppler imaging (TDI) parameters (S’ and E’) and in valvular regurgitation gradient 
for both groups. Moreover, significantly greater RVOT dimensions (31.6 ± 2.6 vs 30.9 ± 3.0 mm, p = 0.04), RVD (39.3 ± 7.0 
vs 32.7 ± 5.2 mm, p = 0.003), and RAA (21.4 ± 4.4 vs 18.1 ± 4.2 mm, p = 0.02) as well as reduction in TAPSE (20.9 ± 5.3 
vs 25.0 ± 4.3 mm, p = 0.01) were observed in patients having ≥ 10 episodes of obstructive apnea (OA) per hour.
Conclusions: In moderate-to-severe OSAS patients, right ventricular (RV) enlargement was observed together with RV dys-
function as measured by TAPSE. Examination using TDI is not superior to standard echocardiography for the detection of heart 
pathology in OSAS patients. Right heart pathology is present predominantly in patients with obstructive apnea.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is 
the most common type of sleep-related breathing 
disorder caused by repetitive airway collapse 
during sleep, affecting approximately 2–10% of 
the middle-aged global population [1, 2]. It is 
characterized by daytime sleepiness; however, 
serious complications such as hypertension, isch-
emic heart disease, diabetes, and stroke have also 
been linked to OSAS [3–6]. Moreover, breathing 
disturbances may alter pulmonary circulation, re-
sulting in the deterioration of right heart function 
and structure. As current studies emphasize the 
influence of RV function on outcomes, accurate 
RV assessment is essential in OSAS patients [7].
Obstructive sleep apnea syndrome has been 
linked to alterations in cardiac structure, but the 
pathophysiologic mechanisms between these car-
diac abnormalities and OSAS are not completely 
understood [8]. It is now considered that recur-
rent hypoxia in OSAS leads to oxidative stress 
and increased sympathetic tone, consequently 
raising the levels of circulating inflammatory 
markers leading to endothelial dysfunction and 
elevated blood pressure, which eventually pro-
motes blood-clotting disturbances [9]. As chest 
pressure becomes highly negative during respi-
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ration in OSAS patients, the decreased pressures 
according to the respiratory cycle have a negative 
effect on pulmonary and systemic hemodynam-
ics, mainly by increasing afterload [10]. The re-
lationship between OSAS and RV wall thickness 
as well as right heart dimensions was previously 
reported; however, analysis of the data has been 
inconclusive [11].
The aims of this study were (I) to evaluate 
heart structure and function in patients diag-
nosed with OSAS; (II) to assess the influence of 
the degree of OSAS on changes in the structure 
and function of the right heart, and finally; (III) 
to assess the correlation between sleep indexes 
and right heart structure and function.
Materials and methods
Patients
A cohort of 77 consecutive patients admitted 
to the Department of Diagnostic Medicine due 
to suspected OSAS was examined using echo-
cardiography and polysomnography. Patients 
were eligible if they were over 18 years of age 
and were able to give informed consent. The 
exclusion criteria were as follows: inability to 
perform the testing procedures or to self-operate 
a continuous positive airway pressure (CPAP) 
device, severe or moderate valvular disease, heart 
failure of any etiology, diminished ejection frac-
tion (< 50%), congenital heart disease, pulmonary 
hypertension, history of pulmonary embolism, 
uncontrolled arterial hypertension, uncontrolled 
or severe asthma, chronic obstructive pulmonary 
disease (COPD) or any other pulmonary disease, 
other untreated or uncontrolled diseases (diabetes 
mellitus, hypo/hyperthyroidism, renal failure, 
hepatic failure), patients treated previously with 
CPAP or any other effective treatment for OSAS. 
All procedures performed in this study were in 
accordance with the ethical standards of the 
institutional and national research committee 
and with the 1964 Helsinki Declaration and its 
later amendments. All subjects gave their written 
informed consent to participate in the study (Jagi-
ellonian University Ethics Committee approval 
number 112.6120.2.2016) (Table 1).
Sleep study
The occurrence and severity of daytime 
sleepiness was assessed using the Epworth Sleep-
iness Scale (ESS). All patients enrolled in this 
study underwent an overnight sleep study. A stan-
dardized recording sleep-monitoring system 
(Embletta MPR, type III according to American 
Academy of Sleep Medicine, AASM) was used to 
perform a nocturnal sleep study in all patients and 
control subjects. Standard recommendations of 
sleep scoring criteria were used [12]. Electrocar-
diography, airflow analysis, and pulse oximetry 
were performed. Ventilatory flows, at both the 
nose and mouth, were measured with airflow 
cannulas. Respiratory movements of the chest 
and abdomen were monitored using inductive 
plethysmography belts. Body position was deter-
mined using a built-in gyro and position sensor, 
providing the following position outputs: supine, 
right, left, prone, or upright. Arterial oxygen sat-
uration (SpO2) was measured transcutaneously 
with a finger pulse oximeter.
Respiratory events were scored using the 
2012 AASM criteria [13]. Obstructive apnea (OA) 
was defined as a ≥ 90% reduction in the respi-
Table 1. Baseline demographic characteristics of the 
study cohort
Patients without 





and severe OSAS 
(n = 50)
Age 53.9 ± 11.0 60.3 ± 10.3
Sex
  Male 16 (20%) 32 (42%)
  Female 14 (18%) 15 (20%)
BMI [kg/m²] 29.1 ± 5.3 34.1±6.0
NT-proBNP [pg/ml] 75.1 ± 70.9 98.8±120.3
Hypertension 16 (59%) 41 (82%)
Diabetes mellitus 2 (7%) 15 (30%)
Prediabetes 7 (26%) 12 (24%)
Dyslipidemia 19 (70%) 42 (84%)
Active smoker 3 (11%) 9 (18%)
Prior smoker 12 (44%) 15 (30%)
Hypothyroidism 5 (19%) 12 (24%)
Medication
  ACEi/ARB 9 (33%) 30 (60%)
  ß-blockers 7 (26%) 31 (62%)
  CCB 5 (19%) 18 (36%)
  Insulin 0 (0%) 5 (10%)
  Diuretics 8 (29%) 18 (36%)
  Statin 10 (37%) 24 (48%)
ACEi — angiotensin converting enzyme inhibitors; ARB - angiotensin receptor 
blockers; BMI — body-mass index; CCB — calcium channel blockers; NT-proB-
NP — N-terminal part of the propeptide of BNP; OSAS — obstructive sleep 
apnea syndrome.
The values for moderate and severe OSAS group do not differ significantly as 
compared to no and mild OSAS group
Michał Harańczyk et al., Influence of sleep apnea on right heart
495www.journals.viamedica.pl
ratory airflow amplitude lasting at least 10 sec-
onds. Hypopnea (H) was defined as a 30–89% 
reduction in the respiratory airflow amplitude 
lasting at least 10 seconds and accompanied by 
a decrease of at least 3% in oxygen saturation. 
Apnea was described as central (CA) in the 
absence of thoracoabdominal motion. Mixed 
apnea (MIX) was defined as an event which met 
apnea criteria and was associated with absent 
respiratory effort in the initial part of the event, 
followed by resumption of respiratory effort 
in the second part of the event. The average 
number of episodes of apnea and hypopnea 
per hour was defined as the apnea-hypopnea 
index (AHI). Obstructive sleep apnea syndrome 
was defined as an AHI of > 5 per hour, when 
clinical symptoms were present. Desaturation 
was defined as a decrease in the SpO2 of 3% 
or more from baseline, and oxygen desaturation 
index (ODI) was calculated as the total number 
of desaturation episodes per hour. Subjects were 
classified into 4 groups according to AHI: pa-
tients without OSAS (AHI < 5/h), patients with 
mild OSAS (AHI 5–14/h), patients with moderate 
OSAS (AHI 15–29/h), and patients with severe 
OSAS (AHI ≥ 30/h). 
Echocardiography
All patients underwent transthoracic echo-
cardiography using a Philips IE33 device (trans-
ducer X5-1; 1.3 to 4.2 MHz). Two-dimensional 
(2-D) echocardiographic imaging in standard 
views was conducted, including conventional 
2-D, Doppler, Color-Doppler and Tissue Doppler 
imaging (TDI). Examinations were performed 
in the left lateral decubitus and supine posi-
tions. Echocardiograms were recorded from 
standard parasternal, suprasternal, subcostal, 
and apical images. The RV and right atrial (RA) 
parameters were measured from the right ventric-
ular-focused 4-chamber view. Tissue Doppler im-
aging was performed from the apical 4-chamber 
view with the pulse wave directed towards the 
lateral tricuspid annulus, aligned parallel to the 
motion of the free lateral wall towards the apex. 
Assessment of TDI parameters included peak 
systolic (S’) tricuspid annular velocity and peak 
early (E’) diastolic tricuspid annular velocity. The 
same position was used to assess tricuspid annu-
lar plane systolic excursion (TAPSE). Tricuspid 
valve flow pattern was obtained, determining 
the regurgitant flow velocity [14]. All echocar-
diographic measurements were obtained by an 
observer blinded to sleep test data and other 
patient characteristics (Figure 1).
Statistical analysis
The Shapiro-Wilk test was used to deter-
mine if variables were normally distributed. 
Continuous variables are presented as means 
and standard deviations. The Student’s t-test for 
continuous variables was performed to assess for 
differences between the groups. Chi-square test 
was used to examine differences in proportion. 
The accepted statistical significance threshold 
was established as a p-value of < 0.05.
Results
Patient characteristics
The group consisted of more males (48 pa-
tients, 62%) than females and the mean age was 
58.1 ± 11.0 years. The average body-mass in-
dex (BMI) was 32.4 ± 6.2. Among the patients, 
57 (74%) had hypertension, 17 (22%) had dia-
betes mellitus type 2, 19 (25%) had prediabetes, 
61 (79%) had hypercholesterolemia, 5 (6%) had 
a history of deep vein thrombosis, and 7 (9%) had 
superficial venous thrombosis in the past. Asthma 
was present in 5 (6%) patients, while 12 (16%) 
patients were active smokers and 27 (35%) were 
ex-smokers. The following were the most fre-
quently used drugs in the study group: beta-block-
ers in 38 (49%) patients, statins in 34 (44%) pa-
tients, ACE-inhibitors in 23 (30%) patients, ARBs 
in 16 (21%) patients, and diuretics in 26 (34%) 
patients. Baseline demographic data for moderate 
and severe OSAS group did not differ significantly 
as compared to no and mild OSAS group.
Sleep study
After an overnight complete sleep study, 
comprising at least 4 hours of sleep, 50 pa-
tients were classified as having moderate-to-se-
Figure 1. Flow-chart of the study design.
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vere OSAS (AHI ≥ 15/h), while the other 27 pa-
tients were classified as having mild or no OSAS 
(AHI < 15/h) and served as control subjects. Sleep 
study variables acquired from both groups are 
shown in Table 2.
Association between OSAS 
and echocardiographic evaluation
The general quality of echocardiographic 
images was high (Table 3). All individuals had 
normal left ventricular (LV) systolic function. 
Furthermore, the patients did not have significant 
valvular heart disease, according to the exclusion 
criteria. Mild mitral regurgitation was present in 
63 (81%) patients, mild tricuspid regurgitation 
was present in 59 (77%) patients, 3 (4%) patients 
had moderate tricuspid regurgitation, 2 (3%) pa-
tients had moderate mitral regurgitation, while 
mild aortic regurgitation was present in 1 (1%) 
patient. Additionally, transvalvular gradients 
measured across the aortic, mitral, tricuspid, 
and pulmonary valves were within the normal 
range (Table 4).
Patients with a diagnosis of moderate-to-se-
vere OSAS had greater RVOT dimensions when 
compared to patients without diagnosed OSAS or 
patients with mild OSAS. A similar relationship 
between the examined groups was demonstrated 
regarding the RAA and RVD dimensions. The 
analysis of RV systolic function revealed a signif-
icant difference in the mean TAPSE, with moder-
ate-to-severe OSAS patients having a decreased 
TAPSE There were no significant differences in 
TDI parameters (S’ and E’) when comparing mod-
erate-to-severe OSAS patients to mild OSAS pa-
tients or those without OSAS. Similarly, between 
the two groups there was no significant difference 
in valvular regurgitation gradient (Table 5).
In order to examine the impact of OSAS on 
cardiac function, the association between sleep 
study variables and several echocardiographic 
parameters as measured by 2-D, M-mode, and 
TDI were analyzed. A statistically significant 
difference in RVOT dimension was demonstrat-
ed for patients with severe OSAS (AHI ≥ 30/h), 
indicating RV enlargement. Significantly greater 
RVOT dimensions, RVD, and RAA were observed 
in patients with ≥ 10 OA episodes per hour, while 
no significant differences in these parameters 
were observed depending on the degree of CA and 
H. Interestingly, the occurrence of at least 1 MIX 
episode during sleep was associated with a lower 
Table 2. Sleep study results
Patients without OSAS 
and with mild OSAS 
(n = 27)
Patients with moderate 
and severe OSAS 
(n = 50)
P-value
ESS 7.5 ± 4.2 9.3 ± 6 ns
AHI (h¯¹) 9 ± 3.5 37.4 ± 19.2 < 0.0001
OA (h¯¹) 2 ± 1.9 17.1 ± 17.7 < 0.0001
CA (h¯¹) 0.5 ± 0.7 1.3 ± 2.6 0.03
MIX (h¯¹) 0.1 ± 0.2 3.4 ± 6.3 0.03
H (h¯¹) 6.5 ± 2.9 15.8 ± 8.5 < 0.0001
SpO2 (%) 93.5 ± 18 90.7 ± 3.7 0.0004
ODI (h¯¹) 9 ± 4 38.8 ± 3.3 < 0.0001
Advised CPAP treatment 0 38
ESS — Epworth Sleepiness Scale score; AHI — apnea-hypopnea index; OA — obstructive apnea; CA — central apnea; MIX — mixed apnea; H — hypopnea; mean 
SpO2 — mean blood oxygen saturation; ODI — oxygen desaturation index; CPAP — continuous positive airway pressure; OSAS — obstructive sleep apnea syndrome
Table 3. Echocardiographic image quality in obstructive 
sleep apnea syndrome (OSAS) patients








E’ — peak early diastolic tricuspid annular velocity; RAA — right atrial area; 
RVD — right ventricular diameter; RVOT — right ventricular outflow tract; S’ — 
peak early systolic tricuspid annular velocity; TAPSE — tricuspid annular plane 
systolic excursion; TRPG — tricuspid regurgitant peak gradient
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TAPSE. Moreover, patients with mean saturation 
levels < 95% during the overnight sleep study 
had a significantly larger RAA.
Discussion
The main finding of our study was the pres-
ence of RV enlargement and dysfunction in OSAS 
patients, which was diagnosed by standard 2-D 
echocardiography with M-mode function. We 
evaluated patients with various stages of OSAS 
who had symptoms of daytime sleepiness, but 
not having other significant cardiac or pulmonary 
diseases, or other comorbidities affecting the 
pulmonary circulation.
Analysis of individual parameters from the 
sleep study revealed a significant relationship 
between OA and right heart structure remodel-
ing, and a reduction in longitudinal RV systolic 
function presented as TAPSE. This suggests the 
potential influence of OA episodes on the mor-
phology and function of right heart structure. In 
Table 4. Echocardiographic parameters





LVEF [%] 63.7 ± 3.0 63.2 ± 3.8 ns
RVOT [mm] 30.9 ± 2.4 32.6 ± 3.6 0.05
RVD [mm] 32.2 ± 4.7 36.5 ± 7.0 0.02
RAA [cm2] 17.2 ± 3.2 21.1 ± 4.8 0.002
S’[cm/s] 13.9 ± 2.7 15.0 ± 3.7 ns
E’ [cm/s] 10.6 ± 2.5 11.0 ± 3.1 ns
TAPSE [mm] 25.8 ± 4.4 21.9 ± 4.5 0.004
TRPG [mm Hg] 21.2 ± 6.9 23.5 ± 5.7 ns
LVEF — left ventricular ejection fraction; RVOT — right ventricular outflow tract; RVD — right ventricular diameter; RAA — right atrial area; S’ — peak early systolic 
tricuspid annular velocity; E’ — peak early diastolic tricuspid annular velocity; OSAS — obstructive sleep apnea syndrome; TAPSE — tricuspid annular plane systolic 
excursion; TRPG — tricuspid regurgitant peak gradient
Table 5. OSAS severity and echocardiographic results
RVOT RVD RAA TAPSE
AHI < 30 (h¯¹)














OA < 10 (h¯¹)














CA < 1 (h¯¹)














MIX < 1 (h¯¹)














H < 15 (h¯¹)





























AHI — apnea-hypopnea index; OA — obstructive apnea; CA — central apnea; MIX — mixed apnea; H — hypopnea; OSAS — obstructive sleep apnea syndrome; 
SpO2 — mean blood oxygen saturation; RVOT — right ventricular outflow tract; RVD — right ventricular diameter; RAA — right atrial area; TAPSE — tricuspid annular 
plane systolic excursion
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contrast, no difference between the frequency of 
H and CA in both groups suggests that these types 
of disorders have no significant correlation with 
the severity of OSAS and its effects on heart struc-
ture. This has been confirmed by several studies, 
which showed that OA may lead to more severe 
SpO2 desaturation when compared to hypopneic 
episodes [15, 16]. It has been argued that because 
apneic episodes arise as the result of complete 
upper airway collapse, they may have a more 
serious pathophysiologic impact than hypopneas, 
which are a consequence of partial upper airway 
collapse. Indeed, apneas should be regarded as 
more significant than hypopneas when assessing 
the severity of OSAS and its related impact on 
long-term cardiac risk. 
Numerous studies evaluating right heart 
structure and function, based on echocardio-
graphic measurements, showed significant 
changes in both RV morphology and efficien-
cy in OSAS patients [17]. It has recently been 
demonstrated, that 3-dimensional (3D) echo-
cardiography and speckle tracking echocardi-
ography revealed lower 3D RV ejection fraction 
and global RV strain in patients with moderate 
and severe OSAS compared with controls [18]. 
This is in complete agreement with Shivalkar et 
al. [19], who found that among 43 patients with 
severe OSAS there was RV dilatation. Contrary 
to results reported in our study, they also showed 
reduced TDI systolic and diastolic velocities in 
the left and right ventricles. However, several 
researchers did not demonstrate any differences 
in RV structure and function, while conventional 
echocardiography remained the main method of 
evaluation [20, 21]. 
Karamanzanis et al. [1] described the cor-
relation between OSAS severity and the degree 
of RV systolic dysfunction, which was reflected 
in TAPSE values. Similar conclusions can be 
drawn from a study by Tugcu et al. [22], which 
evaluated newly diagnosed OSAS patients. The 
most commonly used parameter in the quantifi-
cation of RV function is TAPSE, owing to its ease 
of interpretation and the fact that the tracing can 
be acquired quickly [23]. Assessment of TAPSE 
is based on a one-dimensional measurement, 
and therefore, represents only a part of global 
RV function. However, this may represent the 
majority of total RV function, because longitudi-
nal contraction accounts for up to 80% of short-
ening of the chamber. Anatomically, this can be 
explained by the arrangement of muscle fibers, 
which run mostly longitudinally and obliquely. 
A potential disadvantage of TAPSE is the fact that 
it is angle- and load- dependent. In addition, there 
remains controversy regarding cut-off values and 
prognostic value in the prediction of cardiovas-
cular events [24].
On the other hand, TAPSE is a reliable echo-
cardiographic tool as it correlates well with RV 
ejection fraction as determined by radionu-
clide angiography or cardiac magnetic resonance 
(CMR) [25]. The other advantage of TAPSE, which 
is confirmed by our study, is the possibly of being 
derived in the vast majority of patients, regardless 
of difficulties in acquiring high-quality images 
of the entire RV free wall. Furthermore, TAPSE 
is considered to have strong predictive power in 
various diseases. For example, it is associated 
with a lower cardiac index and worse survival 
in patients with several diseases. However, there 
is a lack of long-term studies examining the 
impact of this parameter in OSAS patients [26, 
27]. Despite its simplicity and some limitations 
mentioned above, our study shows that TAPSE 
links sleep study variables to RV systolic function 
disturbances and appears to confirm the effect of 
OSAS on RV function.
In contrast, Gulay et al. [28] did not detect 
a significant correlation between TAPSE and poly-
somnographic variables when studying a group 
of 60 OSAS patients, although the mean AHI 
(24.5/h; 6–98) in this study was lower than our 
observed values. Similarly, Hammerstingl et al. 
[29] observed in a group of 82 patients that RV 
functional parameters such as TAPSE and RV-MPI 
were not significantly decreased in patients with 
increased AHI at baseline and after 6 months of 
CPAP treatment.
Other echocardiographic techniques fre-
quently used for assessing RV function include 
the measurement of myocardial strain by two-di-
mensional speckle tracking echocardiography 
(STE) and fractional area change (FAC). Strain 
evaluation requires specialized software. In 
addition, RV STE assessment should take into 
account the differences resulting from the various 
myocardial tracking algorithms used by software 
producers [30]. On the other hand, conventional 
measures of RV longitudinal contractility, such 
as TAPSE or TDI derived S’, reflect RV basal 
function, whereas RV strain and FAC account for 
a greater area of RV free wall deformation and 
are not prone to the errors that can occur due 
to translational motion. However, both of these 
techniques require good visibility of endocardial 
borders and may constitute a challenge in the 
assessment of RV function in patients with OSAS, 
especially in those who are obese.
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Surprisingly, our study showed no significant 
difference in the assessment of TDI parame-
ters. Similarly, the components of TDI evaluation 
are susceptible to comparable limitations as those 
of TAPSE. By analogy, S’ measures only a small 
region of the RV and it cannot be used in patients 
with regional wall-motion abnormalities. More-
over, it is not dependent on the presence of opti-
mal image quality. S’ belongs to the most common 
parameters describing RV functionality, although 
there exists much controversy in the literature 
related to its utility in OSAS patients. Altekin et 
al. [31] assessed the relationship between AHI 
and RV function, expressed as S’. In their study, 
which included a similar group of 79 patients 
with various stages of OSAS, no correlation was 
found between those parameters. Similarly, in 
a study conducted by Zhou et al. [32], assess-
ment of S’ revealed no significant difference be-
tween healthy subjects and patients with OSAS. 
On the other hand, they observed regional RV 
systolic dysfunction and a diminished inflow 
EF and global EF as measured by real-time 3-D 
echocardiography in moderate and severe OSAS 
patients. Additionally, Kepez et al. [33] did not 
show a difference in S’ values, but they noted that 
the regional pattern of RV dysfunction correlated 
with the severity of OSAS, when assessed with 
strain analysis. 
Our study has some limitations. No other 
measurement of right heart structures was at-
tempted. It should be remembered that CMR im-
aging is a reference standard for the assessment of 
cardiac function and structure. However, echocar-
diographic techniques do have some advantages 
over CMR, including wider availability, lower 
cost, less patient distress related to claustro-
phobia, and the ability to examine patients with 
contraindications to CMR, such as those with 
implanted pacemakers or defibrillators. Moreover, 
our study population was relatively small but 
proportional to comparable studies performed 
in OSAS patients. 
Conclusions
In summary, RV enlargement along with RV 
dysfunction, as measured by TAPSE, was ob-
served in moderate-to-severe OSAS patients. Ex-
amination with TDI is not superior to standard 
echocardiography in the detection of heart pa-
thology in OSAS patients. Right heart pathology 
is present predominantly in patients with ob-
structive apnea. Further prospective studies using 
echocardiography are needed to demonstrate the 
impact of observed changes on the long-term 
prognosis of OSAS patients. 
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